Autologous Stem Cell Based Therapies Market By Type and Application - Global Industry Analysis & Forecast to 2027
Published On : February 2019 Pages : 180 Category: Biotechnology Report Code : HC022437
Autologous Stem Cell Based Therapies Market By Type (Resident Cardiac Stem Cells, Embryonic Stem Cell, Umbilical Cord Blood Stem Cells) Application (Autoimmune Diseases, Neurodegenerative Disorders, Cardiovascular Diseases) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Autologous Stem Cell Based Therapies Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Autologous stem-cell transplantation otherwise called autogeneic, autogenic, or autogenous foundational microorganism transplantation or auto-SCT is the autologous transplantation of immature stem cells which is, transplantation in which the undifferentiated cells or stem cells are taken from an individual, collected, and offered back to a similar individual later.
Drivers and Restraints
The market is anticipated to profit by the consideration of new cell types, which thus, give significant chances to organizations to strengthen their market position. Accordingly, the number of organizations associated with cell treatment advancement has expanded immensely over the previous years. Rising subsidizing from government just as private associations to help cell treatment clinical preliminaries, presentation of compelling rules for cell treatment fabricating, and demonstrated adequacy of products are a portion of the essential development stimulants for the market.
Regional Insights
North America is anticipated to hold the biggest share in the worldwide market all through the estimated time frame. Solid administrative structure for advancing cell treatment advancement, staggering expense of treatments in the U.S., and existence of a heap of organizations are advancing the development of the territorial market.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- JCR Pharmaceuticals Co., Ltd.
- Osiris Therapeutics, Inc.
- Cells for Cells
- Fibrocell Science, Inc.
- PHARMICELL Co., Ltd
- Celgene Corporation
- Kolon TissueGene, Inc.
- MEDIPOST
- Stemedica Cell Technologies, Inc
- NuVasive, Inc
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Autologous Stem Cell Based Therapies Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
· Resident Cardiac Stem Cells
· Embryonic Stem Cell
· Umbilical Cord Blood Stem Cells
· Autologous Stem Cell Based Therapies Market, By Product type, Estimates and Forecast, 2017-2027 ($Million)
· Autoimmune Diseases
· Neurodegenerative Disorders
· Cardiovascular Diseases
· Autologous Stem Cell Based Therapies Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
· North America
§ North America Autologous Stem Cell Based Therapies Market, By Country
o U.S. Autologous Stem Cell Based Therapies Market
o Canada Autologous Stem Cell Based Therapies Market
o Mexico Autologous Stem Cell Based Therapies Market
· Europe
§ Europe Autologous Stem Cell Based Therapies Market, By Country
o Germany Autologous Stem Cell Based Therapies Market
o UK Autologous Stem Cell Based Therapies Market
o France Autologous Stem Cell Based Therapies Market
o Russia Autologous Stem Cell Based Therapies Market
o Italy Autologous Stem Cell Based Therapies Market
o Rest of Europe Autologous Stem Cell Based Therapies Market
· Asia-Pacific
§ Asia-Pacific Autologous Stem Cell Based Therapies Market, By Country
o China Autologous Stem Cell Based Therapies Market
o Japan Autologous Stem Cell Based Therapies Market
o South Korea Autologous Stem Cell Based Therapies Market
o India Autologous Stem Cell Based Therapies Market
o Southeast Asia Autologous Stem Cell Based Therapies Market
o Rest of Asia-Pacific Autologous Stem Cell Based Therapies Market
· South America
§ South America Autologous Stem Cell Based Therapies Market
o Brazil Autologous Stem Cell Based Therapies Market
o Argentina Autologous Stem Cell Based Therapies Market
o Columbia Autologous Stem Cell Based Therapies Market
o Rest of South America Autologous Stem Cell Based Therapies Market
· Middle East and Africa
§ Middle East and Africa Autologous Stem Cell Based Therapies Market
o Saudi Arabia Autologous Stem Cell Based Therapies Market
o UAE Autologous Stem Cell Based Therapies Market
o Egypt Autologous Stem Cell Based Therapies Market
o Nigeria Autologous Stem Cell Based Therapies Market
o South Africa Autologous Stem Cell Based Therapies Market
o Rest of MEA Autologous Stem Cell Based Therapies Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Autologous Stem Cell Based Therapies Market, By Type
5.1. Introduction
5.2. Global Autologous Stem Cell Based Therapies Revenue and Market Share by Type (2017-2027)
5.2.1. Global Autologous Stem Cell Based Therapies Revenue and Revenue Share by Type (2017-2027)
5.3. Resident Cardiac Stem Cells
5.3.1. Global Resident Cardiac Stem Cells Revenue and Growth Rate (2017-2027)
5.4. Embryonic Stem Cell
5.4.1. Global Embryonic Stem Cell Revenue and Growth Rate (2017-2027)
5.5. Umbilical Cord Blood Stem Cells
5.5.1. Global Umbilical Cord Blood Stem Cells Revenue and Growth Rate (2017-2027)
6. Autologous Stem Cell Based Therapies Market, By Application
6.1. Introduction
6.2. Global Autologous Stem Cell Based Therapies Revenue and Market Share by Application (2017-2027)
6.2.1. Global Autologous Stem Cell Based Therapies Revenue and Revenue Share by Application (2017-2027)
6.3. Autoimmune Diseases
6.3.1. Global Autoimmune Diseases Revenue and Growth Rate (2017-2027)
6.4. Neurodegenerative Disorders
6.4.1. Global Neurodegenerative Disorders Revenue and Growth Rate (2017-2027)
6.5. Cardiovascular Diseases
6.5.1. Global Cardiovascular Diseases Revenue and Growth Rate (2017-2027)
7. Autologous Stem Cell Based Therapies Market, By Region
7.1. Introduction
7.2. Global Autologous Stem Cell Based Therapies Revenue and Market Share by Regions
7.2.1. Global Autologous Stem Cell Based Therapies Revenue by Regions (2017-2027)
7.3. North America Autologous Stem Cell Based Therapies by Countries
7.3.1. North America Autologous Stem Cell Based Therapies Revenue and Growth Rate (2017-2027)
7.3.2. North America Autologous Stem Cell Based Therapies Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Autologous Stem Cell Based Therapies by Countries
7.4.1. Europe Autologous Stem Cell Based Therapies Revenue and Growth Rate (2017-2027)
7.4.2. Europe Autologous Stem Cell Based Therapies Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Autologous Stem Cell Based Therapies by Countries
7.5.1. Asia-Pacific Autologous Stem Cell Based Therapies Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Autologous Stem Cell Based Therapies Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Autologous Stem Cell Based Therapies by Countries
7.6.1. South America Autologous Stem Cell Based Therapies Revenue and Growth Rate (2017-2027)
7.6.2. South America Autologous Stem Cell Based Therapies Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Autologous Stem Cell Based Therapies by Countries
7.7.1. Middle East and Africa Autologous Stem Cell Based Therapies Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Autologous Stem Cell Based Therapies Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. JCR Pharmaceuticals Co., Ltd.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Osiris Therapeutics, Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Cells for Cells
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Fibrocell Science, Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. PHARMICELL Co., Ltd
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Celgene Corporation
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Kolon TissueGene, Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. MEDIPOST
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Stemedica Cell Technologies, Inc
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. NuVasive, Inc
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Global Autologous Stem Cell Based Therapies Market Competition, by Manufacturer
9.1. Global Autologous Stem Cell Based Therapies Revenue and Market Share by Manufacturer (2017-2017)
9.2. Global Autologous Stem Cell Based Therapies Price By Region (2017-2017)
9.3. Top 5 Autologous Stem Cell Based Therapies Manufacturer Market Share
9.4. Market Competition Trend
10. Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.1. Global Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Autologous Stem Cell Based Therapies Market Forecast by Regions (2017-2027)
10.2.1. North America Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.1.1. United States Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.1.2. Canada Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.1.3. Mexico Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.2. Europe Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.2.1. Germany Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.2.2. France Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.2.3. UK Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.2.4. Russia Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.2.5. Italy Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.3. Asia-Pacific Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.3.1. China Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.3.2. Japan Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.3.3. Korea Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.3.4. India Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.4. South America Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.4.1. Brazil Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.4.2. Argentina Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.4.3. Columbia Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.4.4. Rest of South America Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.5. Middle East and Africa Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.5.3. Egypt Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.5.4. Nigeria Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.5.5. South Africa Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.5.6. Turkey Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Autologous Stem Cell Based Therapies Market Forecast (2017-2027)
10.3. Autologous Stem Cell Based Therapies Market Forecast by Type (2017-2027)
10.3.1. Autologous Stem Cell Based Therapies Forecast by Type (2017-2027)
10.3.2. Autologous Stem Cell Based Therapies Market Share Forecast by Type (2017-2027)
10.4. Autologous Stem Cell Based Therapies Market Forecast by Application (2017-2027)
10.4.1. Autologous Stem Cell Based Therapies Forecast by Application (2017-2027)
10.4.2. Autologous Stem Cell Based Therapies Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Autologous Stem Cell Based Therapies Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Autologous Stem Cell Based Therapies Revenue and Revenue Share by Type (2017-2018)
Figure Global Resident Cardiac Stem Cells Revenue and Growth Rate (2017-2018)
Figure Global Embryonic Stem Cell Revenue and Growth Rate (2017-2018)
Figure Global Umbilical Cord Blood Stem Cells Revenue and Growth Rate (2017-2018)
Table Global Autologous Stem Cell Based Therapies Revenue and Revenue Share by Application (2017-2018)
Figure Global Autoimmune Diseases Revenue and Growth Rate (2017-2018)
Figure Global Neurodegenerative Disorders Revenue and Growth Rate (2017-2018)
Figure Global Cardiovascular Diseases Revenue and Growth Rate (2017-2018)
Table Global Autologous Stem Cell Based Therapies Revenue by Regions (2017-2018)
Figure North America Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure North America Autologous Stem Cell Based Therapies Revenue and Growth Rate (2017-2018)
Figure North America Autologous Stem Cell Based Therapies by Countries (2017-2018)
Figure North America Autologous Stem Cell Based Therapies Revenue (Million USD) by Countries (2017-2018)
Figure United States Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure United States Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Canada Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Mexico Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Europe Autologous Stem Cell Based Therapies Revenue and Growth Rate (2017-2018)
Figure Europe Autologous Stem Cell Based Therapies by Countries (2017-2018)
Figure Europe Autologous Stem Cell Based Therapies Revenue (Million USD) by Countries (2017-2018)
Figure Germany Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Germany Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure France Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure UK Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Russia Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Italy Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Rest of Europe Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Asia-Pacific Autologous Stem Cell Based Therapies Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Autologous Stem Cell Based Therapies by Countries (2017-2018)
Figure Asia-Pacific Autologous Stem Cell Based Therapies Revenue (Million USD) by Countries (2017-2018)
Figure China Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure China Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Japan Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Korea Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure India Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Southeast Asia Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure South America Autologous Stem Cell Based Therapies Revenue and Growth Rate (2017-2018)
Figure South America Autologous Stem Cell Based Therapies by Countries (2017-2018)
Figure South America Autologous Stem Cell Based Therapies Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Brazil Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Argentina Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Columbia Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Rest of South America Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Middle East and Africa Autologous Stem Cell Based Therapies Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Autologous Stem Cell Based Therapies by Countries (2017-2018)
Figure Middle East and Africa Autologous Stem Cell Based Therapies Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Saudi Arabia Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure United Arab Emirates Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Egypt Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Nigeria Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure South Africa Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Turkey Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Autologous Stem Cell Based Therapies Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2017-2018)
Table JCR Pharmaceuticals Co., Ltd. Autologous Stem Cell Based Therapies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Osiris Therapeutics, Inc. Autologous Stem Cell Based Therapies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cells for Cells Autologous Stem Cell Based Therapies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Fibrocell Science, Inc. Autologous Stem Cell Based Therapies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table PHARMICELL Co., Ltd Autologous Stem Cell Based Therapies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Celgene Corporation Autologous Stem Cell Based Therapies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Kolon TissueGene, Inc. Autologous Stem Cell Based Therapies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table MEDIPOST Autologous Stem Cell Based Therapies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Stemedica Cell Technologies, Inc Autologous Stem Cell Based Therapies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table NuVasive, Inc Autologous Stem Cell Based Therapies Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Autologous Stem Cell Based Therapies Market Share by Manufacturer
Figure Global Autologous Stem Cell Based Therapies Revenue and Market Share by Manufacturer
Table Global Autologous Stem Cell Based Therapies Price by Region (2017-2017)
Figure Top 5 Autologous Stem Cell Based Therapies Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Autologous Stem Cell Based Therapies Revenue (Millions USD) and Growth Rate (2018-2025)
Table Autologous Stem Cell Based Therapies Market Forecast by Regions (2018-2025)
Figure North America Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure United States Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Canada Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Mexico Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Europe Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Germany Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure France Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure UK Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Russia Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Italy Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Rest of Europe Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Asia-Pacific Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure China Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Japan Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Korea Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure India Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Southeast Asia Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure South America Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Brazil Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Argentina Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Columbia Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Rest of South America Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Middle East and Africa Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Saudi Arabia Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure United Arab Emirates Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Egypt Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Nigeria Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure South Africa Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Turkey Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Autologous Stem Cell Based Therapies Market Forecast (2018-2025)
Figure Global Autologous Stem Cell Based Therapies Forecast by Type (2018-2025)
Figure Global Autologous Stem Cell Based Therapies Market Share Forecast by Type (2018-2025)
Figure Global Autologous Stem Cell Based Therapies Forecast by Type (2018-2025)
Figure Global Autologous Stem Cell Based Therapies Forecast by Application (2018-2025)
Figure Global Autologous Stem Cell Based Therapies Market Share Forecast by Application (2018-2025)
Figure Global Autologous Stem Cell Based Therapies Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|